In the APP/PS1 mouse model of Alzheimer’s disease, Aβ decreases brain BDNF expression, but BDNF treatment inhibits Aβ deposition and ameliorates cognitive decline [69]. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.